Back
AtriCure, Inc. Vs. Immunovant, Inc. Industry Stock Comparison
Sell
34
ATRC
AtriCure, Inc.
Last Price:
$40.39
Seasonality Move:
-5.18%
Sell
33
IMVT
Immunovant, Inc.
Last Price:
$25.61
Seasonality Move:
-30.75%
Sell
34
AtriCure, Inc. (ATRC)
is a Sell
Is AtriCure, Inc. a Buy, Sell or Hold?
-
The current AtriCure, Inc. [ATRC] share price is $40.43. The Score for ATRC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
ATRC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Immunovant, Inc. (IMVT)
is a Sell
Is Immunovant, Inc. a Buy, Sell or Hold?
-
The current Immunovant, Inc. [IMVT] share price is $25.61. The Score for IMVT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
IMVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATRC Stock Price Chart
What is AtriCure, Inc.'s stock price today?
-
The AtriCure, Inc. share price today is $40.43The current trend is moderately bullish and ATRC is experiencing selling pressure, which indicates risk of future bearish movement.
IMVT Stock Price Chart
What is Immunovant, Inc.'s stock price today?
-
The Immunovant, Inc. share price today is $25.61The current trend is moderately bullish and IMVT is experiencing selling pressure, which indicates risk of future bearish movement.
ATRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.32 | Buy |
| Relative Strength Index (14 RSI): | 57.56 | Buy |
| Chaikin Money Flow: | -177077 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.53 - 41.43) | Buy |
| Bollinger Bands (100): | (33.93 - 38.71) | Buy |
IMVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.03 | Buy |
| Relative Strength Index (14 RSI): | 54.65 | Buy |
| Chaikin Money Flow: | -839230 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ATRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.77 | Sell |
| 20-day SMA: | 39.64 | Buy |
| 50-day SMA: | 36.76 | Buy |
| 200-day SMA: | 34.42 | Buy |
| 8-day EMA: | 40.62 | Sell |
| 20-day EMA: | 39.59 | Buy |
| 50-day EMA: | 37.67 | Buy |
| 200-day EMA: | 35.16 | Buy |
IMVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.6 | Sell |
| 20-day SMA: | 24.97 | Buy |
| 50-day SMA: | 23.46 | Buy |
| 200-day SMA: | 17.88 | Buy |
| 8-day EMA: | 26.22 | Sell |
| 20-day EMA: | 25.37 | Buy |
| 50-day EMA: | 23.33 | Buy |
| 200-day EMA: | 20.42 | Buy |
AtriCure, Inc. Earnings Growth & ATRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.11 per share.
Immunovant, Inc. Earnings Growth & IMVT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.13 per share, and a decrease next year of $0.05 per share.
AtriCure, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Immunovant, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||